BridgeMD
New treatment option for Difficult Airway
Official title SEALion: Study on Supplemental Oxygenation Via Nasal Cannula for Young Children During Intubation
ClinicalTrials.gov ID: NCT06683599
What this study is testing
- What it's testing
- Tracheal intubation in neonates can be technically challenging, even for experienced pediatric anesthesiologists, with a high first-attempt success rate crucial to ensure safety. Intubation, while life-saving for children with circulatory shock or respiratory failure, carries risks of severe desaturation that can lead to hypoxic encephalopathy, cardiac arrest, or death.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 52
You may be able to join if
- Pediatric patients requiring oral or nasal tracheal intubation for elective, semi-elective, or urgent surgical and non-surgical procedures.
- Neonates and infants up to 52 weeks post-conceptual age.
- Written informed consent provided by legal guardians prior to the intervention.
You likely can't join if
- Prediction of difficult intubation based on physical examination or a history of previous difficult intubation.
- Requirement for an alternative technique to direct laryngoscopy to secure the airway.
- Specific conditions, such as congenital heart disease requiring FiO₂ \< 1.0, or cardiopulmonary collapse necessitating advanced life support and...
The study team makes the final eligibility decision.
Where it's taking place
- Perth, Western Australia, Australia
- São Paulo, Brazil
- Uppsala, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 minute to 52 weeks. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Perth, Western Australia, Australia; São Paulo, Brazil; Uppsala, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.